Healthcare Roundup – Healthcare rallies as Presidential vote count continues, Novavax inks pact with Australia Life Science
Healthcare Roundup – Canopy Growth switches listing to Nasdaq, Brazil on board with resumption of J&J COVID-19 vaccine study Life Science
CEPI Extends Partnership With Clover Biopharmaceuticals to Fund COVID-19 Vaccine Candidate Through Global Phase 2/3 Study to Licensure Life Science
Nov. 5, 2020 – Diversified Investing Strategies Agenda Live – Life Science, Fintech, Clean Tech Sectors Covered! Cannabis, Energy, Life Science, Technology
Healthcare Roundup – CytoDyn to file marketing application for leronlimab, Takeda submits supplemental application for Cabometyx Life Science
Developing New Treatments with a Proprietary Cell-Based Therapy Platform | Lineage Cell Therapeutics, Inc. (NYSE American: LCTX) Life Science
Healthcare Roundup – Lilly ends COVID-19 antibody trial, Moderna inks COVID-19 vaccine supply deal in Qatar Life Science
Healthcare Roundup – FDA getting cold feet on EUA nod for COVID-19 vaccines, AstraZeneca COVID-19 deal allows 20% gross profit Life Science
Healthcare Roundup – FDA OKs Gilead’s remdesivir, Moderna completes enrollment for Phase 3 study of Covid-19 vaccine Life Science
Healthcare Roundup – J&J’s daratumumab extends survival in first-line multiple myeloma, Death reported in Brazil study of AstraZeneca COVID-19 vaccine Life Science
Healthcare Roundup – CytoDyn study of leronlimab for COVID-19 passes first interim tollgate, Novavax to present COVID-19 vaccine data Life Science
Healthcare Roundup – CVS looks to hire another 15,000 employees, Pfizer and Moderna pivotal studies on COVID-19 vaccines near enrollment targets Life Science
Healthcare Roundup – Sinovac’s COVID-19 vaccine offered by Chinese city for emergency use, CytoDyn to discuss DSMC’s review of interim analysis in COVID-19 Life Science
Healthcare Roundup – Remdesivir has little effect on mortality, Gilead Science lands WHO distinction for remdesivir Life Science
